NEW YORK (GenomeWeb News) – Gen-Probe is spinning off its industrial testing assets into a new, independently operated company that will develop molecular assays for biopharmaceutical production, water and food safety testing, and other applications, the firm said today.

The new company will be called Roka Bioscience, and Gen-Probe will hold a 19.9 percent stake in the firm. It will begin operations as an independent entity immediately, with 18 Gen-Probe employees joining Roka.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.